In oncology, Novartis develops advanced medicines for the treatment of various types of cancer. The focus is on precise, targeted therapies that attack cancer cells while preserving healthy tissue as much as possible. The goal is to enable more effective treatments and better outcomes for patients at all stages of the disease.